These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9660655)

  • 1. Regional Development 1996. Quebec biotechnology: the quiet revolution.
    Prouty AF
    Nat Biotechnol; 1996 Aug; 14(8):955-6. PubMed ID: 9660655
    [No Abstract]   [Full Text] [Related]  

  • 2. Regional Development 1996. The Caledonian way.
    Quinn N
    Nat Biotechnol; 1996 Aug; 14(8):962-3. PubMed ID: 9660658
    [No Abstract]   [Full Text] [Related]  

  • 3. Today's biotech industry in India.
    Suresh N
    Biotechnol J; 2009 Mar; 4(3):291-4. PubMed ID: 19296434
    [No Abstract]   [Full Text] [Related]  

  • 4. The quiet revolution.
    Nat Biotechnol; 2003 Jul; 21(7):715. PubMed ID: 12833072
    [No Abstract]   [Full Text] [Related]  

  • 5. Biotech boom.
    Jayaraman KS
    Nat Biotechnol; 2005 Sep; 23(9):1183-4. PubMed ID: 16151411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Despite size difference, Monsanto, AHP to merge.
    Fox JL
    Nat Biotechnol; 1998 Jul; 16(7):612-3. PubMed ID: 9661184
    [No Abstract]   [Full Text] [Related]  

  • 7. The number on biotech indexes.
    Jacobs T
    Nat Biotechnol; 2005 Nov; 23(11):1356. PubMed ID: 16273059
    [No Abstract]   [Full Text] [Related]  

  • 8. R&D deals boom in 2004.
    Lawrence S
    Nat Biotechnol; 2005 Sep; 23(9):1036. PubMed ID: 16151383
    [No Abstract]   [Full Text] [Related]  

  • 9. New pharma-biotech company formation in India.
    Saberwal G
    Nat Biotechnol; 2006 May; 24(5):499-501. PubMed ID: 16680124
    [No Abstract]   [Full Text] [Related]  

  • 10. Biotechnology and sustainability: the role of transatlantic cooperation in research and innovation.
    Aguilar A; Bochereau L; Matthiessen-Guyader L
    Trends Biotechnol; 2008 Apr; 26(4):163-5. PubMed ID: 18295918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Europe caught in innovation quagmire.
    Mitchell P
    Nat Biotechnol; 2005 Sep; 23(9):1029. PubMed ID: 16151378
    [No Abstract]   [Full Text] [Related]  

  • 12. Stepping up to the plate.
    Nat Immunol; 2008 Jan; 9(1):1. PubMed ID: 18087245
    [No Abstract]   [Full Text] [Related]  

  • 13. Biotech as Bush bows out.
    Lorenzo A
    Nat Biotechnol; 2008 Jan; 26(1):15-8. PubMed ID: 18183006
    [No Abstract]   [Full Text] [Related]  

  • 14. OECD says industrial biotech not realizing potential.
    Niiler E
    Nat Biotechnol; 2001 Jun; 19(6):493-4. PubMed ID: 11385413
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial: Biotech in the financial crisis.
    Jungbauer A
    Biotechnol J; 2009 Aug; 4(8):1095. PubMed ID: 19685457
    [No Abstract]   [Full Text] [Related]  

  • 16. The development of China's medical biotech industry needs to be driven by innovation.
    Yu Z; Dai Y
    Biotechnol J; 2006 Nov; 1(11):1253-7. PubMed ID: 17068752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A testing approach based on tiny doses still awaits big results.
    Coombs A
    Nat Med; 2008 Aug; 14(8):796. PubMed ID: 18685584
    [No Abstract]   [Full Text] [Related]  

  • 18. The promise of South African biotech.
    Akermann B; Kermani F
    Drug Discov Today; 2006 Nov; 11(21-22):962-5. PubMed ID: 17055404
    [No Abstract]   [Full Text] [Related]  

  • 19. The 1992 biotechnology agenda: a message for candidates Bush and Clinton.
    Duzan SA
    Healthspan; 1992 Sep; 9(8):12-5. PubMed ID: 10122052
    [No Abstract]   [Full Text] [Related]  

  • 20. Left in the dust of the campaign trail.
    Nat Biotechnol; 2000 Nov; 18(11):1119. PubMed ID: 11062387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.